189 related articles for article (PubMed ID: 3532786)
1. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial.
Bombardier C; Ware J; Russell IJ; Larson M; Chalmers A; Read JL
Am J Med; 1986 Oct; 81(4):565-78. PubMed ID: 3532786
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in patients receiving auranofin therapy: confirmation of efficacy using nontraditional health status measures.
Morgan GJ
Scand J Rheumatol Suppl; 1986; 63():29-35. PubMed ID: 3299681
[TBL] [Abstract][Full Text] [Related]
3. A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis.
Carette S; Calin A; McCafferty JP; Wallin BA
Arthritis Rheum; 1989 Feb; 32(2):158-65. PubMed ID: 2645874
[TBL] [Abstract][Full Text] [Related]
4. The cost effectiveness of auranofin: results of a randomized clinical trial.
Thompson MS; Read JL; Hutchings HC; Paterson M; Harris ED
J Rheumatol; 1988 Jan; 15(1):35-42. PubMed ID: 3127585
[TBL] [Abstract][Full Text] [Related]
5. Auranofin (SK&F) in early rheumatoid arthritis: results from a 24-month double-blind, placebo-controlled study. Effect on clinical and biochemical assessments.
Johnsen V; Borg G; Trang LE; Berg E; Brodin U
Scand J Rheumatol; 1989; 18(5):251-60. PubMed ID: 2688083
[TBL] [Abstract][Full Text] [Related]
6. A comparison of health-related quality-of-life measures for rheumatoid arthritis research. The Auranofin Cooperating Group.
Bombardier C; Raboud J
Control Clin Trials; 1991 Aug; 12(4 Suppl):243S-256S. PubMed ID: 1663860
[TBL] [Abstract][Full Text] [Related]
7. Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: a one-year, double-blind, comparative multicenter study.
Schattenkirchner M; Bröll H; Kaik B; Müller-Fassbender H; Rau R; Zeidler H
Klin Wochenschr; 1988 Feb; 66(4):167-74. PubMed ID: 3131571
[TBL] [Abstract][Full Text] [Related]
8. Auranofin versus placebo in the treatment of rheumatoid arthritis.
Wenger ME; Alexander S; Bland JH; Blechman WJ
Am J Med; 1983 Dec; 75(6A):123-7. PubMed ID: 6419593
[TBL] [Abstract][Full Text] [Related]
9. A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
Vischer TL
Ann Rheum Dis; 1988 Jul; 47(7):582-7. PubMed ID: 3041924
[TBL] [Abstract][Full Text] [Related]
10. Auranofin is safe and superior to placebo in elderly-onset rheumatoid arthritis.
Glennås A; Kvien TK; Andrup O; Clarke-Jenssen O; Karstensen B; Brodin U
Br J Rheumatol; 1997 Aug; 36(8):870-7. PubMed ID: 9291856
[TBL] [Abstract][Full Text] [Related]
11. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.
Borg G; Allander E; Lund B; Berg E; Brodin U; Pettersson H; Trang L
J Rheumatol; 1988 Dec; 15(12):1747-54. PubMed ID: 14552308
[TBL] [Abstract][Full Text] [Related]
12. Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial.
Weinblatt ME; Kaplan H; Germain BF; Merriman RC; Solomon SD; Wall B; Anderson L; Block S; Irby R; Wolfe F
Arthritis Rheum; 1990 Mar; 33(3):330-8. PubMed ID: 2180405
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of auranofin in patients with active early rheumatoid arthritis.
Itokazu M; Matsunaga T; Oshita Y
Clin Ther; 1995; 17(1):60-73. PubMed ID: 7758062
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of auranofin as demonstrated by improvement in clinical parameters and decrease in anti-inflammatory usage: a long-term, multicenter study.
Brenol JC; Chahade W; De Freitas GG; De Pádua PM; Rachid A; Samara A; Seda H; Ximenes AC
Scand J Rheumatol Suppl; 1986; 63():37-45. PubMed ID: 3299682
[TBL] [Abstract][Full Text] [Related]
15. Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis.
Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; de Jager J
J Rheumatol; 1988 Jan; 15(1):28-34. PubMed ID: 3280795
[TBL] [Abstract][Full Text] [Related]
16. Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children's Study Group.
Giannini EH; Brewer EJ; Kuzmina N; Shaikov A; Wallin B
Arthritis Rheum; 1990 Apr; 33(4):466-76. PubMed ID: 2183804
[TBL] [Abstract][Full Text] [Related]
17. A three year comparative multicenter study of auranofin (AF) and gold sodium thiomalate (GST) in the treatment of rheumatoid arthritis (RA).
Rau R; Schattenkirchner M; Müller-Fassbender H; Kaik B; Zeidler H
Clin Rheumatol; 1987 Sep; 6 Suppl 2():43-52. PubMed ID: 3121238
[No Abstract] [Full Text] [Related]
18. The moderate intestinal side effects of auranofin do not require prophylactic therapy with a bulkforming agent. Dutch Ridaura Study Group.
van Beusekom HJ; van de Laar MA; Franssen MJ; van Valburg JA; Gijzel WP; Couvée JE
Clin Rheumatol; 1997 Sep; 16(5):471-6. PubMed ID: 9348142
[TBL] [Abstract][Full Text] [Related]
19. Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study.
Rao UR; Naidu MU; Kumar TR; Shobha U; Askar MA; Ahmed N; Sarada P; Venubabu K; Shantaram V; Menon GN
J Rheumatol; 1995 Jul; 22(7):1235-40. PubMed ID: 7562751
[TBL] [Abstract][Full Text] [Related]
20. [Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study].
Klein G; Schwann H; Mirtl B; Thumb N; Mayerhofer F; Singer F; Tausch G; Gaismayer K; Rieder H; Hartweger A
Z Rheumatol; 1988; 47(5):342-6. PubMed ID: 3149087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
